(Press-News.org) CHICAGO, Ill. (March 28, 2011)—Interventional radiologists have completed the first human randomized controlled trial of therapeutic renal denervation or RDN—a procedure that uses a catheter-based probe inserted into the renal artery that emits high-frequency energy to deactivate the nerves near the kidneys (or in the renal artery) that are linked to high blood pressure. The researchers say these results confirm that RDN may be an effective therapy for reducing—and consistently controlling—resistant hypertension when current medications have failed. The results were presented at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.
"Renal denervation, a minimally invasive, effective treatment, appears to be safe in the short term with a low incidence of local complications. Its efficacy to lower blood pressure in patients with resistant high blood pressure will be better evaluated with the results of a subsequent trial," said Marc R. Sapoval, M.D., Ph.D., professor of clinical radiology and chair of the cardiovascular radiology department at Hôpital Européen Georges-Pompidou in Paris, France. "After six months, 39 percent of patients receiving the endovascular denervation treatment had reached the recommended blood pressure level and, overall, 50 percent of patients showed a measurable benefit of the intervention," he added.
"It is estimated that one in every four American adults has high blood pressure. High blood pressure increases the risk of heart and/or kidney disease and stroke because it makes the heart work too hard," Sapoval explained. "The renal sympathetic system, which are the small nerves that carry the signal from the brain to the kidney and back from the kidney to the brain, plays an important role in the regulation of blood pressure levels. The disruption of these nerve fibers has a positive effect on blood pressure levels," he continued.
"Given its impact on the central sympathetic drive, endovascular renal denervation may have applicability in additional disease states such as heart failure, cardio-renal syndrome, hepato-renal syndrome, and in the prevention of progression of chronic kidney disease and hypertension in end-stage renal disease—with the added benefit of helping to raise public awareness on the dramatic burden of this disease," said Sapoval.
This study targeted only patients with resistant essential hypertension, which means that a doctor couldn't find any reason for the condition. Sapoval said the causes of high blood pressure can be wide-ranging, such as a benign tumor in the adrenal gland, stenosis of the renal artery, the taking of certain prescription drugs or other factors.
By randomized assignment, 106 adult patients with uncontrolled hypertension received either oral medication or the renal denervation treatment. Six months after the intervention, systolic pressure (the top number in a blood pressure measurement) fell an average of 32 mmHg (millimeters of mercury, the standard for measuring blood pressure) and diastolic pressure (the smaller number in a blood pressure reading) fell an average of 12 mmHg. This initial cohort has been expanded to a multicenter randomized controlled trial at 24 international sites.
Sapoval conceded that this was a small study, that the work still experimental, and that renal denervation should be performed only by interventional radiologists on screened patients in strictly controlled academic and/or research settings. However, he noted that it shows great promise for those suffering from resistant hypertension. Sapoval remarked that the patients had a short hospital stay for safety reasons, but that the treatment might possibly be performed in an outpatient clinic in the future.
While the treatment's efficacy to lower blood pressure in patients with resistant hypertension will be better evaluated with the results of future trials, the interventional radiologist said that some clinical findings (like hypertension in young patients, hypertension after child bearing, etc.) can also be used by doctors to determine if other specific diagnostic tests are needed to rule out potential causes of the hypertension.
Sapoval stated that the trial was funded by the catheter and specific generator manufacturer and that there is a huge need for more research in independent hands. To that end, there will be an upcoming nationwide U.S. Food and Drug Administration trial involving more than 100 U.S.-based interventional radiology teams. He also stressed that the published results need confirmation by follow-up with the succeeding trial's patients after one and two years. Sapoval hopes that new trials, conducted and funded by public entities, such as the National Institutes of Health in the United States; NICE (the National Institute for Clinical Excellence) in the United Kingdom and the Ministry of Health in France, for example, and similar agencies in other countries, will help researchers to move forward and discern which patients would benefit from this technique, possibly in addition to medication.
INFORMATION:
More information about the Society of Interventional Radiology, interventional radiologists and minimally invasive treatments can be found online at www.SIRweb.org.
Abstract No. 31: "Catheter-based Renal Sympathetic Denervation for the Treatment of Uncontrolled Hypertension—An Overview of Technology, Technique and Recent Clinical Experience," M.R. Sapoval, M. Azizi, G. Bobrie, P. Plouin, all cardiovascular radiology, Hôpital Européen Georges-Pompidou, Paris, France. SIR 36th Annual Scientific Meeting, March 26-31, 2011. This abstract can be found at www.SIRmeeting.org.
About the Society of Interventional Radiology
Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine. Today, interventional oncology is a growing specialty area of interventional radiology. Interventional radiologists can deliver treatments for cancer directly to the tumor without significant side effects or damage to nearby normal tissue.
Many conditions that once required surgery can be treated less invasively by interventional radiologists. Interventional radiology treatments offer less risk, less pain and less recovery time compared to open surgery. Visit www.SIRweb.org.
The Society of Interventional Radiology is holding its 36th Annual Scientific Meeting March 26, 2011, in Chicago, Ill. The theme of the meeting is "IR Rising: Leading Image Guided Medicine," the theme chosen to reflect the optimism and pride the IR community feels as IR continues to revolutionize modern medicine.
Interventional radiology treatment takes blood pressure to new lows -- and results last
Innovative therapy that decreases resistant hypertension may also find use in managing other diseases
2011-03-29
ELSE PRESS RELEASES FROM THIS DATE:
Interventional radiologists advance MS research: Vein-opening treatment safe
2011-03-29
CHICAGO, Ill. (March 28, 2011)—Understanding that angioplasty—a medical treatment used by interventional radiologists to widen the veins in the neck and chest to improve blood flow—is safe may encourage additional studies for its use as a treatment option for individuals with multiple sclerosis, say researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.
"Angioplasty—the nonsurgical procedure of threading a thin tube into a vein or artery to open blocked or narrowed blood vessels—is a safe treatment. Our study will provide ...
Interventional radiologists take lead on reducing disability from dangerous blood clots
2011-03-29
CHICAGO, Ill. (March 28, 2011)—Deep vein thrombosis, or DVT: it's more than just a one-time complication from taking a long plane ride. The Society of Interventional Radiology wants individuals to know the risk factors for this very serious condition, which can lead to post-thrombotic syndrome, pulmonary embolism, permanent damage to the leg and even death.
"Individuals and their doctors need to be aware that in the United States alone about 600,000 people are hospitalized with deep vein thrombosis each year and more than 100,000 people die of resulting pulmonary embolism," ...
Interventional Radiology Y-90 Liver Cancer-busting Treatment: Safe, Fast, Extends Life
2011-03-29
Interventional radiologists have been the leaders in the use of intra-arterial yttrium-90 radioembolization, since its introduction in 2000, to treat liver cancer. Now, new results from a large multi-institutional study show that treating liver tumors with higher doses of Y-90 than previously tried is safe, provides results when chemotherapies have failed, preserves the patient's quality of life—and can be done on an outpatient basis. This study, presented by researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill., further ...
Some ingredients in 'green' products come from petroleum rather than natural sources
2011-03-29
Contact: Michael Bernstein
m_bernstein@acs.org
714-765-2012 (Meeting, March 27-31)
202-872-6042 (Before March 27)
Michael Woods
m_woods@acs.org
714-765-2012 (Meeting, March 27-31)
202-872-6293 (Before March 27)
American Chemical Society
Some ingredients in 'green' products come from petroleum rather than natural sources
ANAHEIM, March 28 , 2011 — With more and more environmentally conscious consumers choosing "green" products, scientists today reported that the first reality check has revealed that the ingredients in those products may ...
From crankcase to gas tank: New microwave method converts used motor oil into fuel
2011-03-29
Contact: Michael Bernstein
m_bernstein@acs.org
714-765-2012 (Meeting, March 27-31)
202-872-6042 (Before March 27)
Michael Woods
m_woods@acs.org
714-765-2012 (Meeting, March 27-31)
202-872-6293 (Before March 27)
American Chemical Society
From crankcase to gas tank: New microwave method converts used motor oil into fuel
This release is also available in Chinese on EurekAlert! Chinese.
ANAHEIM, March 28, 2011 — That dirty motor oil that comes out of your car or truck engine during oil changes could end up in your fuel tank, according to a report ...
Potential new medicines show promise for treating colon cancer, asthma
2011-03-29
Contact: Michael Bernstein
m_bernstein@acs.org
714-765-2012 (Meeting, March 27-31)
202-872-6042 (Before March 27)
Michael Woods
m_woods@acs.org
714-765-2012 (Meeting, March 27-31)
202-872-6293 (Before March 27)
American Chemical Society
Potential new medicines show promise for treating colon cancer, asthma
ANAHEIM, March 28, 2011 — In what they described as the opening of a new era in the development of potentially life-saving new drugs, scientists today reported discovery of a way to tone down an overactive gene involved in colon cancer and ...
Mimicking Mother Nature yields promising materials for drug delivery and other applications
2011-03-29
Contact: Michael Bernstein
m_bernstein@acs.org
714-765-2012 (Meeting, March 27-31)
202-872-6042 (Before March 27)
Michael Woods
m_woods@acs.org
714-765-2012 (Meeting, March 27-31)
202-872-6293 (Before March 27)
American Chemical Society
Mimicking Mother Nature yields promising materials for drug delivery and other applications
ANAHEIM, March 28, 2011 — Mimicking Mother Nature's genius as a designer is one of the most promising approaches for developing new medicines, sustainable sources of food and energy, and other products that society needs ...
Commentary: When creating a new institute, the devil's in the details
2011-03-29
When the recent decision was made to merge the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA) into a yet unnamed institution, there were a lot of questions as to how, and even why, it needed to be done. A commentary piece to be released in the April 2011 issue of Alcoholism: Clinical & Experimental Research, which is currently available at Early View, explores that subject in great detail to analyze its problems and present possible solutions.
One of the main issues, according to leading alcohol researchers who ...
SU physicists first to observe rare particles produced at the Large Hadron Collider at CERN
2011-03-29
Shortly after experiments on the Large Hadron Collider (LHC) at the CERN laboratory near Geneva, Switzerland began yielding scientific data last fall, a group of scientists led by a Syracuse University physicist became the first to observe the decays of a rare particle that was present right after the Big Bang. By studying this particle, scientists hope to solve the mystery of why the universe evolved with more matter than antimatter.
Led by Sheldon Stone, a physicist in SU's College of Arts and Sciences, the scientists observed the decay of a special type of B meson, ...
Marijuana use may hurt intellectual skills in MS patients
2011-03-29
ST. PAUL, Minn. –Any possible pain relief that marijuana has for people with multiple sclerosis (MS) may be outweighed by the drug's apparent negative effect on thinking skills, according to research published in the March 29, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Some clinical trials have reported a mild benefit of marijuana on pain, bladder dysfunction and spasticity in MS, an auto-immune disease that affects the brain and spinal cord.
The researchers studied two groups of 25 people each between the ages of 18 ...
LAST 30 PRESS RELEASES:
Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)
A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets
New scan method unveils lung function secrets
Searching for hidden medieval stories from the island of the Sagas
Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model
Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label
Twelve questions to ask your doctor for better brain health in the new year
Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes
Study identifies genetic cause for yellow nail syndrome
New drug to prevent migraine may start working right away
Good news for people with MS: COVID-19 infection not tied to worsening symptoms
Department of Energy announces $179 million for Microelectronics Science Research Centers
Human-related activities continue to threaten global climate and productivity
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
Unraveling the power and influence of language
Gene editing tool reduces Alzheimer’s plaque precursor in mice
TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Twisted Edison: Bright, elliptically polarized incandescent light
Structural cell protein also directly regulates gene transcription
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
Brain map clarifies neuronal connectivity behind motor function
Researchers find compromised indoor air in homes following Marshall Fire
Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality
Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology
'Glass fences' hinder Japanese female faculty in international research, study finds
Vector winds forecast by numerical weather prediction models still in need of optimization
New research identifies key cellular mechanism driving Alzheimer’s disease
Trends in buprenorphine dispensing among adolescents and young adults in the US
Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility
Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity
[Press-News.org] Interventional radiology treatment takes blood pressure to new lows -- and results lastInnovative therapy that decreases resistant hypertension may also find use in managing other diseases